招银国际作为整体协调人、联席全球协调人助力维立志博IPO成功发行并在香港联交所主板挂牌上市

招银国际
25 Jul

交易概述2025年7月25日,南京维立志博生物科技股份有限公司(“维立志博”,9887.HK)成功在香港联合交易所主板挂牌上市。招银国际担任维立志博在香港IPO的整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。维立志博此次全球发行36,862,500股H股(发售量调整权全部行使后、绿鞋行使前),发行价格为每股H股35.00港元,总募集金额约12.9亿港元(发售量调整权全部行使后、绿鞋...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10